Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

DNA damage, p14ARF, nucleophosmin (NPM/B23), and cancer.

Gjerset RA.

J Mol Histol. 2006 Sep;37(5-7):239-51. Epub 2006 Jul 20. Review.

PMID:
16855788
2.

Regulation of p14ARF through subnuclear compartmentalization.

Gjerset RA, Bandyopadhyay K.

Cell Cycle. 2006 Apr;5(7):686-90. Epub 2006 Apr 1.

PMID:
16627991
3.
4.

Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.

Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, Quelle DE.

Mol Cell Biol. 2005 Feb;25(4):1258-71.

5.

ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.

Brady SN, Yu Y, Maggi LB Jr, Weber JD.

Mol Cell Biol. 2004 Nov;24(21):9327-38.

6.

Sumoylation induced by the Arf tumor suppressor: a p53-independent function.

Tago K, Chiocca S, Sherr CJ.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7689-94. Epub 2005 May 16.

7.

The ARF-B23 connection: implications for growth control and cancer treatment.

Zhang Y.

Cell Cycle. 2004 Mar;3(3):259-62. Epub 2004 Mar 1.

PMID:
14726681
8.

AKT regulates NPM dependent ARF localization and p53mut stability in tumors.

Hamilton G, Abraham AG, Morton J, Sampson O, Pefani DE, Khoronenkova S, Grawenda A, Papaspyropoulos A, Jamieson N, McKay C, Sansom O, Dianov GL, O'Neill E.

Oncotarget. 2014 Aug 15;5(15):6142-67.

9.

B23 and ARF: friends or foes?

Lindström MS, Zhang Y.

Cell Biochem Biophys. 2006;46(1):79-90. Review.

PMID:
16943625
10.

Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y.

Mol Cell. 2003 Nov;12(5):1151-64.

11.

GLTSCR2 promotes the nucleoplasmic translocation and subsequent degradation of nucleolar ARF.

Lee S, Cho YE, Kim SH, Kim YJ, Park JH.

Oncotarget. 2017 Mar 7;8(10):16293-16302. doi: 10.18632/oncotarget.9957.

12.

Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein.

den Besten W, Kuo ML, Williams RT, Sherr CJ.

Cell Cycle. 2005 Nov;4(11):1593-8. Epub 2005 Nov 14.

PMID:
16205118
13.

Reactivating the ARF-p53 axis in AML cells by targeting ULF.

Chen D, Yoon JB, Gu W.

Cell Cycle. 2010 Aug 1;9(15):2946-51. doi: 10.4161/cc.9.15.12355. Epub 2010 Aug 11.

14.

Nucleophosmin is required for DNA integrity and p19Arf protein stability.

Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC, Helin K, Falini B, Pelicci PG.

Mol Cell Biol. 2005 Oct;25(20):8874-86.

15.

The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma.

Mascaux C, Bex F, Martin B, Burny A, Haller A, Paesmans M, Willard-Gallo K, Ninane V, Sculier JP.

Eur Respir J. 2008 Sep;32(3):678-86. doi: 10.1183/09031936.00008408. Epub 2008 May 14.

16.

p14ARF is a component of the p53 response following ionizing irradiation of normal human fibroblasts.

Khan S, Guevara C, Fujii G, Parry D.

Oncogene. 2004 Aug 12;23(36):6040-6.

PMID:
15195142
17.

The ARF tumour suppressor.

Gallagher SJ, Kefford RF, Rizos H.

Int J Biochem Cell Biol. 2006;38(10):1637-41. Epub 2006 Feb 28. Review.

PMID:
16600663
18.

Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.

Lee S, Kim JY, Kim YJ, Seok KO, Kim JH, Chang YJ, Kang HY, Park JH.

Cell Death Differ. 2012 Oct;19(10):1613-22. doi: 10.1038/cdd.2012.40. Epub 2012 Apr 20.

19.

Binding to nucleophosmin determines the localization of human and chicken ARF but not its impact on p53.

Moulin S, Llanos S, Kim SH, Peters G.

Oncogene. 2008 Apr 10;27(17):2382-9. Epub 2007 Oct 29.

PMID:
17968318
20.

Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.

García JF, Villuendas R, Sánchez-Beato M, Sánchez-Aguilera A, Sánchez L, Prieto I, Piris MA.

Am J Pathol. 2002 Feb;160(2):569-78.

Supplemental Content

Support Center